An in vitro assessment of novel chitosan/bimetallic PtAu nanocomposites as delivery vehicles for doxorubicin

Nanomedicine (Lond). 2017 Nov;12(21):2625-2640. doi: 10.2217/nnm-2017-0228. Epub 2017 Oct 2.

Abstract

Aim: To synthesize and functionalize platinum (core)-gold (shell) bimetallic nanoparticles (PtAuBNps) with chitosan and doxorubicin to display favorable pharmacokinetics, biodegradability, biological activity and safety in vitro.

Materials & methods: PtAuBNps and their drug nanocomposites were morphologically and physico-chemically characterized. Binding studies determined the efficiency and stability of the platform. In vitro release kinetics were evaluated under simulated environments, cytotoxicity profiles through MTT and Sulforodhamine B assays and apoptosis induction using the dual EtBr/AO staining.

Results & discussion: The results obtained indicate that functionalized PtAuBNps displayed favorable physio-chemical attributes, high binding capabilities, pH-triggered drug release through zero-order release kinetics, cell-specific cytotoxicity and good colloidal stability.

Conclusion: The positive attributes of this novel delivery system bodes well for future in vivo studies.

Keywords: bimetallic nanoparticles; cancer; cytotoxicity; doxorubicin; gold; platinum.

MeSH terms

  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / metabolism*
  • Antineoplastic Agents / pharmacology
  • Apoptosis / drug effects
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Chitosan / chemistry*
  • Doxorubicin / chemistry
  • Doxorubicin / metabolism*
  • Doxorubicin / pharmacology
  • Drug Carriers / chemistry*
  • Drug Liberation
  • Drug Stability
  • Gold / chemistry
  • Humans
  • Metal Nanoparticles / chemistry*
  • Nanocomposites / chemistry*
  • Particle Size
  • Platinum / chemistry
  • Surface Properties

Substances

  • Antineoplastic Agents
  • Drug Carriers
  • Platinum
  • Gold
  • Doxorubicin
  • Chitosan